Diagnosis of exercise-induced anaphylaxis: current insights [Corrigendum]

by Pravettoni V, Incorvaia C
Published 2016-11-01

Patient-reported outcomes and considerations in the management of COPD: focus on indacaterol/glycopyrronium bromide

by Ridolo E, Pellicelli I, Gritti B, Incorvaia C
Published 2019-01-01

New combinations in the treatment of COPD: rationale for aclidinium–formoterol

by Incorvaia C, Montagni M, Makri E, Ridolo E
Published 2016-02-01

Two decades with omalizumab: what we still have to learn

by Incorvaia C, Mauro M, Makri E, Leo G, Ridolo E
Published 2018-10-01

Seroprevalence of IgG anti-Toxocara species antibodies in a population of patients with suspected allergy

by Qualizza R, Incorvaia C, Grande R, Makri E, Allegra L
Published 2011-11-01

Striving for optimal bronchodilation: focus on olodaterol

by Incorvaia C, Montagni M, Makri E, Riario-Sforza GG, Ridolo E
Published 2016-03-01

Role of indacaterol and the newer very long-acting β2-agonists in patients with stable COPD: a review

by Ridolo E, Montagni M, Olivieri E, Riario-Sforza GG, Incorvaia C
Published 2013-09-01

Omalizumab, an anti-immunoglobulin E antibody: state of the art

by Incorvaia C, Mauro M, Russello M, Formigoni C, Riario-Sforza GG, Ridolo E
Published 2014-02-01

Shrinking the room for invasive ventilation in hypercapnic respiratory failure

by Scarpazza P, Incorvaia C, Melacini C, Cattaneo R, Bonacina C, Riario-Sforza GG, Casali W
Published 2013-03-01

New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis

by Frati F, Cecchi L, Scala E, Ridolo E, Dell'Albani I, Makrì E, Pajno G, Incorvaia C
Published 2014-09-01

In children allergic to ragweed pollen, nasal inflammation is not influenced by monosensitization or polysensitization

by Gelardi M, Bosoni M, Morelli M, Beretta S, Incorvaia C, Buttafava S, Landi M, Masieri S, Frati F, Quaranta N, Zuccotti GV
Published 2016-04-01

New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Corrigendum]

by Frati F, Cecchi L, Scala E, Ridolo E, Dell'Albani I, Makrì E, Pajno GB, Incorvaia C
Published 2015-06-01

Seasonal changes in nasal cytology in mite-allergic patients

by Gelardi M, Peroni DG, Incorvaia C, Quaranta N, De Luca C, Barberi S, Dell'Albani I, Landi M, Frati F, de Beaumont O
Published 2014-03-01

Requirements for acquiring a high-quality house dust mite extract for allergen immunotherapy

by Frati F, Incorvaia C, David M, Scurati S, Seta S, Padua G, Cattaneo E, Cavaliere C, Di Rienzo A, Dell'Albani I, Puccinelli P
Published 2012-05-01

5-grass pollen tablets achieve disease control in patients with seasonal allergic rhinitis unresponsive to drugs: a real-life study

by Pastorello EA, Losappio L, Milani S, Manzotti G, Fanelli V, Pravettoni V, Agostinis F, D'Arcais AF, Dell'Albani I, Puccinelli P, Incorvaia C, Frati F
Published 2013-12-01

Long-term survival in elderly patients with a do-not-intubate order treated with noninvasive mechanical ventilation

by Riario-Sforza GG, Pravettoni C, Bencini S, Cattaneo R, Melacini C, Bonacina C, Bernareggi M, Usai P, Raschi S, di Franco G, Amboni P, Incorvaia C, Passalacqua G, Scarpazza P, Casali W
Published 2011-04-01